Get the Stockscreener App
17.05
6.56%
1.05
Pulse Biosciences Inc stock is traded at $17.05, with a volume of 164.91K.
It is up +6.56% in the last 24 hours and up +12.47% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
See More
Previous Close:
$16.00
Open:
$16.19
24h Volume:
164.91K
Relative Volume:
0.97
Market Cap:
$1.15B
Revenue:
-
Net Income/Loss:
$-46.13M
P/E Ratio:
-20.99
EPS:
-0.8123
Net Cash Flow:
$-34.10M
1W Performance:
+5.51%
1M Performance:
+12.47%
6M Performance:
-12.43%
1Y Performance:
-20.81%
1-Day Range:
$16.13
$17.25
1-Week Range:
$15.21
$17.25
52-Week Range:
$13.77
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
17.05 | 1.05B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | Oppenheimer | Outperform |
| Jul-27-21 | Initiated | Stephens | Overweight |
| Mar-11-21 | Initiated | Maxim Group | Buy |
| Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
| May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Price action breakdown for Pulse Biosciences Inc.Market Growth Report & Smart Allocation Stock Tips - Newser
Best data tools to analyze Pulse Biosciences Inc. stockJuly 2025 Weekly Recap & Low Risk High Reward Trade Ideas - Newser
Can Pulse Biosciences Inc. hit a new high this month2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Pulse Biosciences Inc. stock momentum explainedPortfolio Gains Report & Proven Capital Preservation Methods - Newser
Using portfolio simulators with Pulse Biosciences Inc. includedJuly 2025 Catalysts & Weekly High Momentum Picks - Newser
How moving averages guide Pulse Biosciences Inc. trading2025 Winners & Losers & Safe Entry Momentum Tips - Newser
What’s the recovery path for long term holders of Pulse Biosciences Inc.2025 Macro Impact & Consistent Income Trade Ideas - Newser
What high frequency data says about Pulse Biosciences Inc.Weekly Trend Recap & Verified Short-Term Trading Plans - Newser
Implied Analyst Target Price of $70.96 for iShares Morningstar Small-Cap ETF (ISCB) Suggests 16% Gain Potential. - AInvest
Multi asset correlation models including Pulse Biosciences Inc.Bear Alert & Risk Controlled Daily Plans - Newser
What Fibonacci levels say about Pulse Biosciences Inc. reboundNew Guidance & Free Technical Pattern Based Buy Signals - Newser
Will Pulse Biosciences Inc. see short term momentumInflation Watch & Smart Money Movement Alerts - Newser
Can you recover from losses in Pulse Biosciences Inc.July 2025 Closing Moves & Safe Entry Point Identification - Newser
Will Pulse Biosciences Inc. Hold Gains Into Close2025 Stock Rankings & Growth-Oriented Investment Plans - classian.co.kr
Custom watchlist performance reports with Pulse Biosciences Inc.2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
What makes Pulse Biosciences Inc. stock price move sharplyTrade Performance Summary & Low Drawdown Trading Techniques - thegnnews.com
When is the best time to buy Pulse Biosciences Inc. stockEarnings Growth Summary & Real-Time Chart Breakout Alerts - Newser
Smart tools for monitoring Pulse Biosciences Inc.’s price action2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser
How Interest Rate Changes Impact Pulse Biosciences Inc. Stock PerformanceJuly 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Using flow based indicators on Pulse Biosciences Inc.July 2025 Patterns & Daily Technical Stock Forecast Reports - Newser
AI Tools Suggest Pulse Biosciences Inc. May Outperform This WeekJuly 2025 Decliners & Smart Swing Trading Techniques - metal.it
Pulse Biosciences Inc. Company Revenue and Profit Trends: A Deep Dive2025 Key Lessons & Safe Capital Allocation Plans - Newser
Short interest data insights for Pulse Biosciences Inc.Weekly Volume Report & Low Risk Entry Point Tips - Newser
Volume spikes in Pulse Biosciences Inc. stock – what they meanJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - Newser
What to expect from Pulse Biosciences Inc. in the next 30 daysMarket Sentiment Report & Weekly Top Performers Watchlists - Newser
Pulse Biosciences outlines initial percutaneous electrode revenue and IDE milestones while expanding nsPFA clinical programs - MSN
Pulse Biosciences Reports Q2 2025 Earnings: Advancements in Clinical Programs and Strong Cash Position - AInvest
Pulse Biosciences shares surpass 200 DMA, rising 4.9% on Thursday. - AInvest
Pulse Biosciences (PLSE) Shares Cross Above 200 DMA - Nasdaq
Competitive Positioning of Pulse Biosciences Inc.: Is It Leading or LaggingPortfolio Value Report & Accurate Trade Setup Notifications - Newser
Pulse Biosciences Surges 10.2% Amid Biotech Sector Turmoil: What's Fueling the Rally? - AInvest
Pulse Biosciences at Canaccord Conference: Strategic Expansion in Ablation By Investing.com - Investing.com Canada
Is it time to cut losses on Pulse Biosciences Inc.Long Setup & Real-Time Chart Breakout Alerts - Newser
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q2 2025 Earnings Call Transcript - Insider Monkey
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pulse Biosciences Inc Stock (PLSE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| UECKER DARRIN | Chief Technology Officer |
Jun 13 '25 |
Sale |
15.98 |
15,000 |
239,700 |
122,872 |
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):